APO Research
Talk to an analyst

APO RESEARCH · REPORT

Long-acting PrEP

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Long-acting PrEP Market Analysis and Forecast 2026-2032

29 December 2025195 pages

Choose your research edition.

Industry ResearchLong-acting PrEP Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Long-acting PrEP Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Long-acting PrEP Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Long-acting PrEP Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Long-acting PrEP Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Long-acting PrEP market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Long-acting PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Long-acting PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Long-acting PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Long-acting PrEP is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Long-acting PrEP include ViiV Healthcare and Gilead Sciences etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Long-acting PrEP, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Long-acting PrEP, also provides the sales of main regions and countries. Of the upcoming market potential for Long-acting PrEP, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Long-acting PrEP sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Long-acting PrEP market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Long-acting PrEP sales, projected growth trends, production technology, application and end-user industry.

Long-acting PrEP Segment by Company

ViiV Healthcare

Gilead Sciences

Long-acting PrEP Segment by Type

Cabotegravir

Lenacapavir

Other

Long-acting PrEP Segment by Application

Hospital

Clinic

Other

Long-acting PrEP Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Long-acting PrEP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Long-acting PrEP and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Long-acting PrEP.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Long-acting PrEP in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Long-acting PrEP manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Long-acting PrEP sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Long-acting PrEP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cabotegravir Major Manufacturers Table 3. Lenacapavir Major Manufacturers Table 4. Other Major Manufacturers Table 5. Global Long-acting PrEP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Clinic Major Manufacturers Table 8. Other Major Manufacturers Table 9. Long-acting PrEP Industry Trends Table 10. Long-acting PrEP Industry Drivers Table 11. Long-acting PrEP Industry Opportunities and Challenges Table 12. Long-acting PrEP Industry Restraints Table 13. Global Long-acting PrEP Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Long-acting PrEP Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Long-acting PrEP Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Long-acting PrEP Revenue Market Share by Region (2021-2026) Table 17. Global Long-acting PrEP Revenue Market Share by Region (2027-2032) Table 18. Global Long-acting PrEP Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Long-acting PrEP Sales by Region (2021-2026) & (K Units) Table 20. Global Long-acting PrEP Sales by Region (2027-2032) & (K Units) Table 21. Global Long-acting PrEP Sales Market Share by Region (2021-2026) Table 22. Global Long-acting PrEP Sales Market Share by Region (2027-2032) Table 23. Global Long-acting PrEP Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Long-acting PrEP Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Long-acting PrEP Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Long-acting PrEP Sales Market Share by Manufacturers (2021-2026) Table 27. Global Long-acting PrEP Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Long-acting PrEP Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Long-acting PrEP Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Long-acting PrEP Manufacturers, Product Type & Application Table 31. Global Long-acting PrEP Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Long-acting PrEP by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Long-acting PrEP Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Long-acting PrEP Revenue Market Share by Type (2021-2026) Table 38. Global Long-acting PrEP Revenue Market Share by Type (2027-2032) Table 39. Global Long-acting PrEP Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 41. Global Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 42. Global Long-acting PrEP Sales Market Share by Type (2021-2026) Table 43. Global Long-acting PrEP Sales Market Share by Type (2027-2032) Table 44. Global Long-acting PrEP Price by Type (2021-2026) & (US$/Unit) Table 45. Global Long-acting PrEP Price by Type (2027-2032) & (US$/Unit) Table 46. Global Long-acting PrEP Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Long-acting PrEP Revenue Market Share by Application (2021-2026) Table 50. Global Long-acting PrEP Revenue Market Share by Application (2027-2032) Table 51. Global Long-acting PrEP Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 53. Global Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 54. Global Long-acting PrEP Sales Market Share by Application (2021-2026) Table 55. Global Long-acting PrEP Sales Market Share by Application (2027-2032) Table 56. Global Long-acting PrEP Price by Application (2021-2026) & (US$/Unit) Table 57. Global Long-acting PrEP Price by Application (2027-2032) & (US$/Unit) Table 58. ViiV Healthcare Company Information Table 59. ViiV Healthcare Business Overview Table 60. ViiV Healthcare Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. ViiV Healthcare Long-acting PrEP Product Portfolio Table 62. ViiV Healthcare Recent Development Table 63. Gilead Sciences Company Information Table 64. Gilead Sciences Business Overview Table 65. Gilead Sciences Long-acting PrEP Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Gilead Sciences Long-acting PrEP Product Portfolio Table 67. Gilead Sciences Recent Development Table 68. North America Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 69. North America Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 70. North America Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 71. North America Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 72. North America Long-acting PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 73. North America Long-acting PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 74. North America Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 75. North America Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 76. North America Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 77. North America Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 78. North America Long-acting PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 79. North America Long-acting PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 80. North America Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. North America Long-acting PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 82. North America Long-acting PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 83. North America Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 84. North America Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 85. North America Long-acting PrEP Sales by Country (2027-2032) & (K Units) Table 86. North America Long-acting PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 87. North America Long-acting PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 88. United States Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 89. Canada Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 90. Mexico Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 91. Europe Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 92. Europe Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 93. Europe Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 94. Europe Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 95. Europe Long-acting PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 96. Europe Long-acting PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 97. Europe Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 100. Europe Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 101. Europe Long-acting PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 102. Europe Long-acting PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 103. Europe Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. Europe Long-acting PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. Europe Long-acting PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. Europe Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 107. Europe Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 108. Europe Long-acting PrEP Sales by Country (2027-2032) & (K Units) Table 109. Europe Long-acting PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 110. Europe Long-acting PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 111. Germany Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 112. France Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 113. U.K. Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 114. Italy Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 115. Russia Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 116. Spain Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 117. Netherlands Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 118. Switzerland Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 119. Sweden Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 120. Poland Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 121. China Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 122. China Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 123. China Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 124. China Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 125. China Long-acting PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 126. China Long-acting PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 127. China Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 128. China Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 129. China Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 130. China Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 131. China Long-acting PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 132. China Long-acting PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Asia Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 134. Asia Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 135. Asia Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 136. Asia Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 137. Asia Long-acting PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 138. Asia Long-acting PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 139. Asia Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 140. Asia Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 141. Asia Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 142. Asia Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 143. Asia Long-acting PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 144. Asia Long-acting PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 145. Asia Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. Asia Long-acting PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. Asia Long-acting PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. Asia Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 149. Asia Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 150. Asia Long-acting PrEP Sales by Country (2027-2032) & (K Units) Table 151. Asia Long-acting PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 152. Asia Long-acting PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 153. Japan Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 154. South Korea Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 155. India Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 156. Australia Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 157. Taiwan Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 158. Southeast Asia Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 159. SAMEA Long-acting PrEP Revenue by Type (2021-2026) & (US$ Million) Table 160. SAMEA Long-acting PrEP Revenue by Type (2027-2032) & (US$ Million) Table 161. SAMEA Long-acting PrEP Sales by Type (2021-2026) & (K Units) Table 162. SAMEA Long-acting PrEP Sales by Type (2027-2032) & (K Units) Table 163. SAMEA Long-acting PrEP Sales Price by Type (2021-2026) & (US$/Unit) Table 164. SAMEA Long-acting PrEP Sales Price by Type (2027-2032) & (US$/Unit) Table 165. SAMEA Long-acting PrEP Revenue by Application (2021-2026) & (US$ Million) Table 166. SAMEA Long-acting PrEP Revenue by Application (2027-2032) & (US$ Million) Table 167. SAMEA Long-acting PrEP Sales by Application (2021-2026) & (K Units) Table 168. SAMEA Long-acting PrEP Sales by Application (2027-2032) & (K Units) Table 169. SAMEA Long-acting PrEP Sales Price by Application (2021-2026) & (US$/Unit) Table 170. SAMEA Long-acting PrEP Sales Price by Application (2027-2032) & (US$/Unit) Table 171. SAMEA Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA Long-acting PrEP Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 173. SAMEA Long-acting PrEP Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 174. SAMEA Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 175. SAMEA Long-acting PrEP Sales by Country (2021-2026) & (K Units) Table 176. SAMEA Long-acting PrEP Sales by Country (2027-2032) & (K Units) Table 177. SAMEA Long-acting PrEP Sales Price by Country (2021-2026) & (US$/Unit) Table 178. SAMEA Long-acting PrEP Sales Price by Country (2027-2032) & (US$/Unit) Table 179. Brazil Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 180. Argentina Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 181. Chile Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 182. Colombia Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 183. Peru Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 184. Saudi Arabia Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 185. Israel Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 186. UAE Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 187. Turkey Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 188. Iran Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 189. Egypt Long-acting PrEP Revenue (2021-2032) & (US$ Million) Table 190. Key Raw Materials Table 191. Raw Materials Key Suppliers Table 192. Long-acting PrEP Distributors List Table 193. Long-acting PrEP Customers List Table 194. Research Programs/Design for This Report Table 195. Authors List of This Report Table 196. Secondary Sources Table 197. Primary Sources List of Figures Figure 1. Long-acting PrEP Image Figure 2. Global Long-acting PrEP Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Long-acting PrEP Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cabotegravir Image Figure 5. Lenacapavir Image Figure 6. Other Image Figure 7. Global Long-acting PrEP Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Long-acting PrEP Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Long-acting PrEP Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Long-acting PrEP Revenue (2021-2032) & (US$ Million) Figure 14. Global Long-acting PrEP Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Long-acting PrEP Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Long-acting PrEP Revenue Market Share by Region (2021-2032) Figure 17. Global Long-acting PrEP Sales (2021-2032) & (K Units) Figure 18. Global Long-acting PrEP Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Long-acting PrEP Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Long-acting PrEP Sales YoY (2021-2032) & (K Units) Figure 21. Europe Long-acting PrEP Sales YoY (2021-2032) & (K Units) Figure 22. China Long-acting PrEP Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Long-acting PrEP Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Long-acting PrEP Sales YoY (2021-2032) & (K Units) Figure 25. Global Long-acting PrEP Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Long-acting PrEP Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Long-acting PrEP Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Long-acting PrEP Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Long-acting PrEP Revenue Market Share by Type (2021-2032) Figure 31. Global Long-acting PrEP Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Long-acting PrEP Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Long-acting PrEP Sales Market Share by Type (2021-2032) Figure 34. Global Long-acting PrEP Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Long-acting PrEP Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Long-acting PrEP Revenue Market Share by Application (2021-2032) Figure 37. Global Long-acting PrEP Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Long-acting PrEP Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Long-acting PrEP Sales Market Share by Application (2021-2032) Figure 40. North America Long-acting PrEP Revenue Share by Type (2021-2032) Figure 41. North America Long-acting PrEP Sales Share by Type (2021-2032) Figure 42. North America Long-acting PrEP Revenue Share by Application (2021-2032) Figure 43. North America Long-acting PrEP Sales Share by Application (2021-2032) Figure 44. North America Long-acting PrEP Revenue Share by Country (2021-2032) Figure 45. North America Long-acting PrEP Sales Share by Country (2021-2032) Figure 46. Europe Long-acting PrEP Revenue Share by Type (2021-2032) Figure 47. Europe Long-acting PrEP Sales Share by Type (2021-2032) Figure 48. Europe Long-acting PrEP Revenue Share by Application (2021-2032) Figure 49. Europe Long-acting PrEP Sales Share by Application (2021-2032) Figure 50. Europe Long-acting PrEP Revenue Share by Country (2021-2032) Figure 51. Europe Long-acting PrEP Sales Share by Country (2021-2032) Figure 52. China Long-acting PrEP Revenue Share by Type (2021-2032) Figure 53. China Long-acting PrEP Sales Share by Type (2021-2032) Figure 54. China Long-acting PrEP Revenue Share by Application (2021-2032) Figure 55. China Long-acting PrEP Sales Share by Application (2021-2032) Figure 56. Asia Long-acting PrEP Revenue Share by Type (2021-2032) Figure 57. Asia Long-acting PrEP Sales Share by Type (2021-2032) Figure 58. Asia Long-acting PrEP Revenue Share by Application (2021-2032) Figure 59. Asia Long-acting PrEP Sales Share by Application (2021-2032) Figure 60. Asia Long-acting PrEP Revenue Share by Country (2021-2032) Figure 61. Asia Long-acting PrEP Sales Share by Country (2021-2032) Figure 62. SAMEA Long-acting PrEP Revenue Share by Type (2021-2032) Figure 63. SAMEA Long-acting PrEP Sales Share by Type (2021-2032) Figure 64. SAMEA Long-acting PrEP Revenue Share by Application (2021-2032) Figure 65. SAMEA Long-acting PrEP Sales Share by Application (2021-2032) Figure 66. SAMEA Long-acting PrEP Revenue Share by Country (2021-2032) Figure 67. SAMEA Long-acting PrEP Sales Share by Country (2021-2032) Figure 68. Long-acting PrEP Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Long-acting PrEP Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cabotegravir
  • Lenacapavir
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • ViiV Healthcare
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Long-acting PrEP Market by Type
  3. 1.2.1 Global Long-acting PrEP Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cabotegravir
  5. 1.2.3 Lenacapavir
  6. 1.2.4 Other
  7. 1.3 Long-acting PrEP Market by Application
  8. 1.3.1 Global Long-acting PrEP Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Long-acting PrEP Market Dynamics
  1. 2.1 Long-acting PrEP Industry Trends
  2. 2.2 Long-acting PrEP Industry Drivers
  3. 2.3 Long-acting PrEP Industry Opportunities and Challenges
  4. 2.4 Long-acting PrEP Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Long-acting PrEP Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Long-acting PrEP Revenue by Region
  3. 3.2.1 Global Long-acting PrEP Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Long-acting PrEP Revenue by Region (2021-2026)
  5. 3.2.3 Global Long-acting PrEP Revenue by Region (2027-2032)
  6. 3.2.4 Global Long-acting PrEP Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Long-acting PrEP Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Long-acting PrEP Sales by Region
  9. 3.4.1 Global Long-acting PrEP Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Long-acting PrEP Sales by Region (2021-2026)
  11. 3.4.3 Global Long-acting PrEP Sales by Region (2027-2032)
  12. 3.4.4 Global Long-acting PrEP Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Long-acting PrEP Revenue by Manufacturers
  2. 4.1.1 Global Long-acting PrEP Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Long-acting PrEP Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Long-acting PrEP Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Long-acting PrEP Sales by Manufacturers
  6. 4.2.1 Global Long-acting PrEP Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Long-acting PrEP Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Long-acting PrEP Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Long-acting PrEP Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Long-acting PrEP Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Long-acting PrEP Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Long-acting PrEP Manufacturers, Product Type & Application
  13. 4.7 Global Long-acting PrEP Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Long-acting PrEP Market CR5 and HHI
  16. 4.8.2 2025 Long-acting PrEP Tier 1, Tier 2, and Tier 3
5 Long-acting PrEP Market by Type
  1. 5.1 Global Long-acting PrEP Revenue by Type
  2. 5.1.1 Global Long-acting PrEP Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Long-acting PrEP Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Long-acting PrEP Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Long-acting PrEP Sales by Type
  6. 5.2.1 Global Long-acting PrEP Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Long-acting PrEP Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Long-acting PrEP Sales Market Share by Type (2021-2032)
  9. 5.3 Global Long-acting PrEP Price by Type
6 Long-acting PrEP Market by Application
  1. 6.1 Global Long-acting PrEP Revenue by Application
  2. 6.1.1 Global Long-acting PrEP Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Long-acting PrEP Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Long-acting PrEP Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Long-acting PrEP Sales by Application
  6. 6.2.1 Global Long-acting PrEP Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Long-acting PrEP Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Long-acting PrEP Sales Market Share by Application (2021-2032)
  9. 6.3 Global Long-acting PrEP Price by Application
7 Company Profiles
  1. 7.1 ViiV Healthcare
  2. 7.1.1 ViiV Healthcare Company Information
  3. 7.1.2 ViiV Healthcare Business Overview
  4. 7.1.3 ViiV Healthcare Long-acting PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 ViiV Healthcare Long-acting PrEP Product Portfolio
  6. 7.1.5 ViiV Healthcare Recent Developments
  7. 7.2 Gilead Sciences
  8. 7.2.1 Gilead Sciences Company Information
  9. 7.2.2 Gilead Sciences Business Overview
  10. 7.2.3 Gilead Sciences Long-acting PrEP Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Gilead Sciences Long-acting PrEP Product Portfolio
  12. 7.2.5 Gilead Sciences Recent Developments
8 North America
  1. 8.1 North America Long-acting PrEP Market Size by Type
  2. 8.1.1 North America Long-acting PrEP Revenue by Type (2021-2032)
  3. 8.1.2 North America Long-acting PrEP Sales by Type (2021-2032)
  4. 8.1.3 North America Long-acting PrEP Price by Type (2021-2032)
  5. 8.2 North America Long-acting PrEP Market Size by Application
  6. 8.2.1 North America Long-acting PrEP Revenue by Application (2021-2032)
  7. 8.2.2 North America Long-acting PrEP Sales by Application (2021-2032)
  8. 8.2.3 North America Long-acting PrEP Price by Application (2021-2032)
  9. 8.3 North America Long-acting PrEP Market Size by Country
  10. 8.3.1 North America Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Long-acting PrEP Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Long-acting PrEP Market Size by Type
  2. 9.1.1 Europe Long-acting PrEP Revenue by Type (2021-2032)
  3. 9.1.2 Europe Long-acting PrEP Sales by Type (2021-2032)
  4. 9.1.3 Europe Long-acting PrEP Price by Type (2021-2032)
  5. 9.2 Europe Long-acting PrEP Market Size by Application
  6. 9.2.1 Europe Long-acting PrEP Revenue by Application (2021-2032)
  7. 9.2.2 Europe Long-acting PrEP Sales by Application (2021-2032)
  8. 9.2.3 Europe Long-acting PrEP Price by Application (2021-2032)
  9. 9.3 Europe Long-acting PrEP Market Size by Country
  10. 9.3.1 Europe Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Long-acting PrEP Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Long-acting PrEP Market Size by Type
  2. 10.1.1 China Long-acting PrEP Revenue by Type (2021-2032)
  3. 10.1.2 China Long-acting PrEP Sales by Type (2021-2032)
  4. 10.1.3 China Long-acting PrEP Price by Type (2021-2032)
  5. 10.2 China Long-acting PrEP Market Size by Application
  6. 10.2.1 China Long-acting PrEP Revenue by Application (2021-2032)
  7. 10.2.2 China Long-acting PrEP Sales by Application (2021-2032)
  8. 10.2.3 China Long-acting PrEP Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Long-acting PrEP Market Size by Type
  2. 11.1.1 Asia Long-acting PrEP Revenue by Type (2021-2032)
  3. 11.1.2 Asia Long-acting PrEP Sales by Type (2021-2032)
  4. 11.1.3 Asia Long-acting PrEP Price by Type (2021-2032)
  5. 11.2 Asia Long-acting PrEP Market Size by Application
  6. 11.2.1 Asia Long-acting PrEP Revenue by Application (2021-2032)
  7. 11.2.2 Asia Long-acting PrEP Sales by Application (2021-2032)
  8. 11.2.3 Asia Long-acting PrEP Price by Application (2021-2032)
  9. 11.3 Asia Long-acting PrEP Market Size by Country
  10. 11.3.1 Asia Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Long-acting PrEP Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Long-acting PrEP Market Size by Type
  2. 12.1.1 SAMEA Long-acting PrEP Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Long-acting PrEP Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Long-acting PrEP Price by Type (2021-2032)
  5. 12.2 SAMEA Long-acting PrEP Market Size by Application
  6. 12.2.1 SAMEA Long-acting PrEP Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Long-acting PrEP Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Long-acting PrEP Price by Application (2021-2032)
  9. 12.3 SAMEA Long-acting PrEP Market Size by Country
  10. 12.3.1 SAMEA Long-acting PrEP Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Long-acting PrEP Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Long-acting PrEP Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Long-acting PrEP Value Chain Analysis
  2. 13.1.1 Long-acting PrEP Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Long-acting PrEP Production Mode & Process
  6. 13.2 Long-acting PrEP Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Long-acting PrEP Distributors
  9. 13.2.3 Long-acting PrEP Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst